Preview

Нейрохирургия

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Только для подписчиков

ХИРУРГИЧЕСКИЕ МЕТОДЫ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ СОСУДИСТОГО СПАЗМА У БОЛЬНЫХ ПОСЛЕ РАЗРЫВА АНЕВРИЗМ СОСУДОВ ГОЛОВНОГО МОЗГА

Полный текст:

Аннотация

В представленном обзоре рассмотрена проблема профилактики и лечения сосудистого спазма у больных с разрывом артериальных аневризм головного мозга. В работе рассмотрены основные механизмы патогенеза вазоспазма, факторы риска его развития. Обсуждаются методики профилактики и лечения спазма, их эффективность и безопасность у больных с нетравматическим субарахноидальным кровоизлиянием. Среди них наибольшее внимание уделено интрацистернальному и внутрижелудочковому введению фармакологических препаратов, в том числе фибринолитиков и вазодилататоров, и транслюминальной баллонной ангиопластике спазмированных артерий. Представлены результаты проводимых исследований.

Об авторах

Владимир Викторович Крылов
МГМСУ им. А.И. Евдокимова
Россия


Александр Владиславович Природов
НИИ скорой помощи им. Н.В. Склифосовского
Россия


Т. К. Кузнецова
Научно-практический центр медицинской помощи детям с пороками развития черепно-лицевой области и врожденными заболеваниями нервной системы ДЗ г. Москвы
Россия


Список литературы

1. Ворлоу Ч.П., Деннис М.С., Ван Гейн Ж., Ханкий Г.Ж., Сандеркок П.А.Г., Бамфорд Ж.М., Вордлау Ж. Инсульт: практическое руководство для врачей. Перев., с англ. - С-Пб., - 1998. - С. 319 - 377.

2. Зефиров А.Л., Черанов С.Ю., Гиниатуллин Р.А., Ситдикова Г.Ф, Гришин С.Н. Медиаторы и синапсы. Казань: КГМУ, 2003. - 14-45 с.

3. Крылов В.В., Гусев С.А., Гусев А.С. Сосудистый спазм при разрыве аневризм головного мозга. Нейрохирургия. - 2000. - № 3. - С 4-13.

4. Крылов В.В., Буров С.А., Дашьян В.Г., Галанкина И.Е. Минимально инвазивная методика локального фибри-нолиза и пункционной аспирации в хирургии нетравматических внутричерепных кровоизлияний «Неотложные состояния в неврологии», М., 2009, с. 179-183.

5. Крылов В.В., Лукьянчиков В.А. Диагностика и хирургическое лечение церебральных аневризм у пациентов пожилого возраста в остром периоде субарахноидального кровоизлияния. // Нейрохирургия. - 2009. - № 3. - С. 37-44.

6. Крылов В.В., Природов А.В., Петриков С.С. Нетравматическое субарахноидальное кровоизлияние: диагностика и лечение. // Неврология, приложение к журналу «Consilium Medicum». - № 1. - 2008. - С. 14-18.

7. От аневризмы к аневризматической болезни. Очерки по патологии нервной системы. Под ред. Медведева Ю.А., Мацко Д.Е. - СПб., 1996. - С. 95-109.

8. Поглазов Б.Ф., Левицкий Д.И. Миозин и биологическая подвижность. М., «Наука», 1982, стр. 160

9. Румянцева С.А., Елисеев Е.В., Силина Е.В. Тактика терапии вазоспазма при сосудистых заболеваниях головного мозга. Consilium Medicum, Неврология. 2009; 1.

10. Хирургия аневризм головного мозга. Под ред. В.В. Крылова. В трех томах. Том 1. Москва, 2011. 344 с.

11. Adams H.P., Kassell N.F., Torner J.C., Haley E.C. Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 1987, 37: 1586-1591.

12. Allen G.S., Ahn H.S., Preziosi T.J. Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983 Mar 17; 308: 11: 619-24.

13. Andaluz N., Zuccarello M. Fenestration of lamina terminalis as a valuable adjunct in aneurysm surgery. Neurosurgery 55: 1050-1059, 2004.

14. Auer L.M., lto Z., Suzuki A., Ohta H. Prevention of Symptomatic Vasospasm by Topically Applied Nimodipine. Aeta Neurochirurgiea. 63, 297-302 (1982).

15. Barth M., Capelle H., Weidauer S. et al. Effect of nicardipini prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurismal SAH: a prospective, randomized, double-blind phase IIa study. Stroke, 2007; 38: 330-336.

16. Barth M., Thom C., Schmiedek P. et al. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipin prolonged-release implants. J Neurosurg. - 2009 - Vol. 110 - p.995-960.

17. Batjer H., Samson D. Use of extracranial-intracranial bypass in the management of symptomatic vasospasm. Neurosurgery. 19: 235-246, 1986

18. van den Bergh W.M., Algra A., van der Sprenkel J.W. et al. Hypomagnesemia аfter aneurysmal subarachnoid hemorrhage. Neurosurgery. 2003 Feb; 52(2): 276-81.

19. Borkar S., Singh M., Mahapatra A. Spinal Cerebrospinal Fluid Drainage for prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage: A Prospective Randomized Controlled Study. 6th International Congress WFSBS / 10th ESBS Congress - Presentation Abstracts. Journal of Neurosurgical Surgery. Part B. 73. Suppl. B2. 2012.

20. Bunc G., Kovacic S., Strnad S. Sympathetic nervous system exclusion following experimental subarachnoid haemorrhage prevents vasospasm in rabbits. Wien Klin Wochenschr. 2000 Jun 16; 112(12): 533-9.

21. Claassen J., Bernardini G.L., Kreiter K. et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 2001, 32: 2012-2020.

22. Clouston J.E., Numaguchi Y., Zoarski G.H. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. Am J Neuroradiol 16: 27-38, 1995.

23. Clyde B.L., Firlik A.D., Kaufmann A.M. et al. Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report. J Neurosurg. 1996 Apr; 84(4): 690-5.

24. Dalbasti T., Karabiyikoglu M., Ozdamar N. et al. Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm. J Neurosurg 2001; 95: 44-50.

25. Dorch N.W.C. A rewiew of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part 1: Incidence and effects. J. Clin. Neurosc. - 1994. - Vol. 1, N1. - P. 19-26.

26. Dorch N.W.C. A rewiew of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part 2: Management. J. Clin. Neurosc. - 1994. - Vol. 1, N2. - P. 78-91.

27. Ehtisham A., Taylor S., Bayless L., Samuels Owen B.; Klein M.W.; Janzen Jeff M. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage induced cerebral vasospasm Journal article, Southern medical journal, Vol. 102, pp. 150-153 (2009).

28. Elliott J.P., Newell D.W., Lam D.J. et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurismal SAH. J Neurosurg 88: 277-284, 1998.

29. Findlay J.M., Kassell N.F., Weir B.K.A. et al. A Randomized trial оf intraoperative, intracisternal tissue plasminogen activator to prevent vasospasm. Neurosurgery 1995; 37: 168-178.

30. Firlik A.D., Kaufmann A.M., Jungreis C.A., Yonas H. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1997; 86: 830-9.

31. Fisher C.M., Kistler J.P., Davis J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980, 6: 1-9.

32. Fray Y.L., Muio G.J., MeDongall G.G., Dean B.L. Cerebral venous thrombosis: combined intrathrombug rtPA and intravenous heparin (see comments). // Stroke. - 1999. - Vol. 30. - N3. - P. 489-494.

33. Fujii Y., Takahashi A., Yoshimoto T. Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev 1995; 18: 7-13.

34. Goellner E., Slavin K.V. Cervical spinal cord stimulation may prevent cerebral vasospasm by modulating sympathetic activity of the superior cervical ganglion at lower cervical spinal level. Med Hypotheses. - 2009 - Vol. 73 - p. 410-413.

35. Gruber A., Ungersbock K., Reinprecht A. et al. Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 1998, 42: 258-267; discussion 267-268.

36. Hanggi D., Beseoglu K., Turowski B., Steiger H.J. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Clinical neurology and neurosurgery 110 (2008) 784790.

37. Hendrix L.E., Dion J.E., Jensen M.E., Phillips C.D., Newman S.A. Papaverine-induced mydriasis. AJNR Am J Neuroradiol 15(4): 716 - 718, 1994.

38. Hijdra A., van Gijn J., Nagelkerke N.J., Vermeulen M., van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 1988, 19: 1250-1256.

39. Hop J.W., Rinkel G.J., Algra A., van Gijn J. Initial loss of consciousness and risk of delayed cerebral ischemia after aneurismal subarachnoid hemorrhage. Stroke 1999, 30: 2268 -2271.

40. Izumi Y., Roussel S., Pinard E., Seylaz J.J. Cereb Blood Flow. Metab - 1991. - Vol. 11, - P. 1025-1030.

41. Jito P., Nakasu Y., Nakasu S. Tissue plasminogen activator levels after single intracisternal injection in patient with subarachnoid hemorrhage. Neurol. Med. Chir (Tokio) 2004, 44 (2): 55-60.

42. Juvela S., Siironen J., Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg 2005, 102: 998-1003.

43. Kassell N.F., Haley J.C., Apperson-Hansen C. Randomized, double-blind, vehicle-controlled trial of tirilazed mesylate patients with aneurysm subarachnoid hemorrhage: a cooperative study in Europe, Australia and New Zeland. J. of Neurosurg. - 1996. - Vol. 84, № 2. - P. 221-228.

44. Kassell N.F., Helm G., Simmons N. et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77(6): 848-52, (1992).

45. Kassell N.F., Torner J.C., Haley E.C. Jr et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990, 73: 18-36.

46. Kassell N.F., Torner J.C., Jane J.A. et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg 1990, 73: 37-47.

47. Kasuya H., Kawashima A., Sasahara A. et al. Development of nicardipine prolonged-release implants for preventing vasospasm. Acta Neurochir Suppl. - 2001 - Vol. 77 - p. 217-220.

48. Kasuya H., Onda H., Sasahara A. et al. Application of Nicardipine Prolonged-release Implants: Analysis of 97 Consecutive Patients with Acute Subarachnoid Hemorrhage. Neurosurgery Volume 56(5), May 2005, pp 895-902.

49. Kawamoto S., Tsutsumi K., Yoshikawa G. et al. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2004 Feb; 100(2): 236-43.

50. Kemp P.A., Gardiner S.M., March J.E., Rubin P.C., Bennett T. Assessment of the effects of endothelin-1 and magnesium sulfate on regional blood flows in conscious rats, by the coloured microsphere reference technique. Br J Pharmacol 126: 621-626, 1999.

51. Khurana V.G., Sohni Y.R., Mangrum W.I. et al. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 2004, 24: 291-297.

52. Kinouchi H., Ogasawara K., Shimizu H. et al. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. Neurol Med Chir (Tokyo) 44, 569-577, 2004.

53. Kodama N. et al. (О-23-339). Abstracts of the Free Papers. Clinical Neurology and Neurosurgery. 11th International Congress of Neurological Surgery. 1997 Jul; 99 Suppl 1: S1-287.

54. Krischek B., Kasuya H., Onda H., Hori T. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first

55. patients. Neurol Med Chir (Tokyo). 2007; 47: 389-94.

56. Lasner T.M., Weil R.J., Riina H.A. et al. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 1997, 87: 381-384.

57. Lee J.Y., Huang D.L., Keep R. et al. Effect of electrical stimulation of the cervical spinal cord on blood flow following subarachnoid hemorrhage. J Neurosurg. - 2008 - Vol. 109 - p.1148-1154.

58. Lüscher T.F., Cooke J.P., Houston D.S. et al. Endothelium-dependent relaxations in human arteries. Mayo Clin Proc. 1987 Jul; 62(7): 601-6.

59. Macdonald R.L., Rosengart A., Huo D., Karrison T. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 2003, 99: 644-652.

60. Magge S.N., Chen H.I., Ramakrishna R. et al. Association of a younger age and symptomatic vasospasm following SAH. J Neurosurg 112: 1208-1215, 2010.

61. Mathis J.M., DeNardo A., Jensen M.E. et al. Transient neurologic events associated with intraarterial papaverine infusion for subarachnoid hemorrhage-induced vasospasm. AJNR Am J Neuroradiol 15(9): 1671-1674, 1994.

62. Maurice-Williams R.S. Aneurysm surgery after the International Subarachnoid Aneurysm Trial (ISAT). J Neurol Neurosurg Psychiatry 2004; 75: 807-8.

63. Miller J.A., Cross D.T., Moran C.J. et al. Severe thrombocytopenia following intraarterial papaverine administration for treatment of vasospasm. J Neurosurg 83 (3): 435-437, 1995.

64. Mitzukami M., Kawase T., Tazawa T. Prevention of vasospasm by early operation with removal of subarachnoid blood. Acta Neurochir 1979, 46: 93-104.

65. Miura K. Changes in Mg++ concentration of CSF after subarachnoid hemorrhage and Mg++-effect on the contractions of bovine cerebral artery. No Shinkei Geka 16: 1251-1259,1988. (Jpn)

66. Mocco J., Ransom E.R., Komotar R.J. et al. Racial differences in cerebral vasospasm: a systematic review of the literature. Neurosurgery 2006, 58: 305-314.

67. Monyer H., Sprengel R., Schoepfer R. et al. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 1992; 256: 1217-21.

68. Mori K., Miyazaki M., Iwata J. et al. Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat. Neurosurg Rev 31: 197-203, 2008

69. Mori K., Miyazaki M., Hara Y. et al. Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage Laboratory investigation. Journal of Neurosurgery. January 2009. 110 (1): 73-78

70. Mori K., Yamamoto T., Miyazaki M. et al. Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cistern magna on cerebral vasospasm in the canine subarachnoid hemorrhage model. Br J Neurosurgery. 2012 Feb; 26(1): 64-68.

71. Mori K., Yamamoto T., Miyazaki M. et al. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model. Journal of Neurosurgery. Apr 2011. 114 (4): 1168-1175

72. Mori K., Yamamoto T., Nakao Y. et al. Initial Clinical Experience of Vasodilatory Effect of Intra-cisternal Infusion of Magnesium Sulfate for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Neurologia medico-chirurgica (Tokio), Vol. 49, pp. 139-145 (2009).

73. Murdoch J., Hall R. Brain protection: physiological and pharmacological considerations. Part I: The physiology of brain injury. Can J. Anaesth. - 1990. - Vol. 37, № 6. - P. 662-675.

74. Nakamura S., Tsubokawa T., Yoshida K. Appearance of collagen fibers in the cerebral vascular wall following subarachnoid hemorrage. Neurol Med Tokyo 1992; 32: 877-82.

75. Niewkamp D.J., de Gansk, Renkelg J. Treatment and outcame of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: systematic review of the literature. // Newrology. - 2000. - N. 247. - P. 117-121.

76. de Oliveira J.G., Beck J., Ulrich C. et al. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurgical Rev 2007, 30: 22-30; discussion 30-31.

77. Pritz M.B. Pupillary Changes After Injection Of Papaverine. Surg Neurol 1994; 41 281-283.

78. Qureshi A.I., Sung G.Y., Suri M.A. et al. Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1999, 44: 967-973; discussion 973-974.

79. Raabe A., Zimmermann M., Vatter H. et al. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurismal patients with severe, medically refractory vasospasm. Neurosurgery 50: 1 006-1014, 2002.

80. Ram Z., Sadeh M., Shacked I. et al. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke. - 1991. - Vol. 22, - P. 922-927.

81. Ramakrishna R., Sekhar L.N., Ramanathan D. et al. Intraventricular tissue plasminogen activator for prevention of vasospasm and hydrocephalus after SAH. Neurosurgery 67: 110-117, 2010.

82. Rath G.P., Mukta L., Prabhakarl H. et al. Haemodynamic changes after intracisternal papaverine instillation during intracranial aneurysmal surgery. British Journal of Anaesthesia 97 (6): 848-50 (2006).

83. Roos Y., Rinkel G., Vermeulen M. et al. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Stroke 2003, 34: 2308 - 2309.

84. Rosengart A.J., Schultheiss K.E., Tolentino J., Macdonald R.L. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007; 38: 8: 2315-21.

85. Rosenwasser R.H., Armonda R.A., Thomas J.E. et al. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999; 44: 975-9

86. Santillan A., Knopman J., Zink W., Gobin Y.P. Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurismal SAH. Neurosurgery 69: 95-102, 2011.

87. Sasaki T., Kodama N., Kawakami M. et al. Urokinase Cisternal Irrigation Therapy for Prevention of SymptomaticVasospasm After Aneurysmal Subarachnoid Hemorrhage: A Study of Urokinase Concentration and the Fibrinolytic System. Stroke 2000; 31; 1256-1262.

88. Satoh A., Sugiyama T., Ooigava H. Prevention of symptomatic vasospasm by continuous cisternal irrigation with mosk-CSF containing a scorbic acid and Mg<2+). Acta Neurochir. Suppl. 2010, 107: 115-118.

89. Segawa H., Saito I., Okada T. et al. Efficacy of intracisternal papaverine on symptomatic vasospasm. No Shinkei Geka. 1986 Jun; 14(7): 847-54.

90. Seifert V., Stolke D., Zimmermann M., Feldges A. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tis sue plasminogen activator (rTPA).A prospective study. Acta Neurochirurgica 128(1-4): 137 - 143,1994.

91. Sepideh A.H., Ogilvy C.S., Barker F. et al. Does intracisternal thrombolysis prevent vasospasm after SAH. Meta-analysis. Neurosurgery 54: 326-335, 2004.

92. Shimosawa T., Takano K., Ando K., Fujita T. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension 2004; 44: 897-902.

93. Smith T.P., Enterline D.S. Endovascular treatment of cerebral vasospasm. J Vasc Interv Radiol. 2000; 11: 547-559.

94. Solenski N.J., Haley E.C. Jr., Kassell N.F. et al. Medical com plications of aneurismal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995, 23: 1007-1017.

95. Suzuki S., Ogane K., Ohkuma H., Iwabuchi T. Efficacy of steroid hormone in solution for intracranial irrigation during aneurismal surgery for prevention of the vasospasm syndrome. Acta neurochir 1994; 131: 184-188.

96. Tadayoshi N., Kazuhide F., Hiroshi N. et al. Surgical procedure and results of cisternal washing terarapy for prevention of cerebral vasospasm following SAH. Acta Neurochirurgica Supplementum, Vol. 110/2, 105-109, 2011.

97. Testa C., Andreoli A., Limoni P. et al. Overall results in 304 consecutive patients with acute spontaneous subarachnoid haemorrhage. Surg. Neurol. - 1985. - Vol. 24. - P. 377-389.

98. Thomas J.E., Rosenwasser R.H., Armonda R.A. et al. Safety of Intrathecal Sodium Nitroprusside for the Treatment and Prevention of Refractory Cerebral Vasospasm and Ischemia in Humans. Stroke. 1999; 30: 1409-1416.

99. Usui M., Saito N., Hoya K., Todo T. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: A retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. // Neurosurgery. - 1994. - N. 34. - P. 235-245.

100. Webb A., Kolenda J., Martin K. et al. The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial Doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care - 2010 - Vol. 12 - p. 159-164.

101. Weir B.K., Kongable G.L., Kassell N.F. et al. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study. J Neurosurg 1998, 89: 405-411.

102. Zambarski J.M., Spetzler R.F., Lee K. S.l. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurismal subarachnoid hemorrhage. J Neurosurg. - 1991 - Vol. 75 - № 2 - p. 189-196.

103. Zubkov Y.N., Nikiforov B.M., Shustin V.A. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 1984; 70: 65-79.

104. Zwienenberg-Lee M., Hartmann J., Rudisill N., Muizelaar J.P. Endovascular management of cerebral vasospasm. Neurosurgery Suppl. 2006; 59: 139-147.

105. Zwienenberg-Lee M., Hartmann J., Rudisill N., Muizelaar J.P. The effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage. Results of a multi-center randomized clinical trial. International Stroke Conference: Feb 7-9, 2007; San Francisco. San Francisco, CA; 2007.


Для цитирования:


Крылов В.В., Природов А.В., Кузнецова Т.К. ХИРУРГИЧЕСКИЕ МЕТОДЫ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ СОСУДИСТОГО СПАЗМА У БОЛЬНЫХ ПОСЛЕ РАЗРЫВА АНЕВРИЗМ СОСУДОВ ГОЛОВНОГО МОЗГА. Нейрохирургия. 2014;(1):104-115.

For citation:


Krylov V.V., Prirodov A.V., Kuznetcova T.K. The surgical methods for prevention and treatment of cerebral angiospasm at patients suffered from rupture of cerebral aneurysms. Russian journal of neurosurgery. 2014;(1):104-115. (In Russ.)

Просмотров: 125


ISSN 1683-3295 (Print)
ISSN 2587-7569 (Online)